Objective : A HPLC method for quantitative determination of Ticlopidine hydrochloride tablets has been developed .

目的：建立盐酸 噻 氯 匹 定片的HPLC含量测定方法。

AIM : To evaluate the clinical and laboratory effects of ticlopidine on granule membrane protein of platelet ( CD 62P CD 63 ) in treating acute cerebral infarction ( ACI ) .

目的：观察 噻 氯 匹 定对急性脑梗死的疗效及对血小板α颗粒膜蛋白（CD62P）及血小板溶酶体完整膜蛋白（CD63）的影响。

Ticlopidine vs aspirin in decreasing blood viscosity and anti_platelet function

噻 氯 匹 定和阿司匹林降低血液粘度和抗血小板作用的比较

PurposeA high performance liquid chromatography ( HPLC ) method for quantitative determination of Ticlopidine hydrochloride capsules had been developed .

目的建立盐酸 噻 氯 匹 定胶囊的高效液相色谱（HPLC）含量测定方法。

Study on the Inhibitory Effect of Ticlopidine on Platelet Aggregation

噻 氯 匹 啶对血小板聚集功能的抑制作用研究

It was also shown thai ticlopidine could significantly inhibit platelet TXB2 formation stimulated by adenosine diphosphate ( ADP ) .

噻 氯 匹 定对ADP诱导的血小板TXB2生成也有显著抑制作用。

The effects of ticlopidine on platelet aggregation ( PAg ) and plasma fibrinogen ( Fg ) level were investigated and compared with those of acetylsalicylic acid ( ASA ) in patients with coronary artery disease ( CAD ) .

本研究对冠心病患者 应用 噻 氯 吡啶对血小板聚集功能（Plateletaggregation，PAg）及血浆纤维蛋白原（fibrinogen，Fg）水平的影响进行探讨并与乙酰水杨酸（acetylsalicyliaacid，ASA）进行比较。

Ticlopidine is a kind of Platelet aggregation inhibitors which is used to prevent and cure the heart brain and other artery circulation obstacle diseases caused by the high aggregation state of blood platelets .

噻 氯 匹 定是一种血小板聚集抑制剂，用于防治因血小板高聚集状态引起的心、脑及其他动脉循环障碍性疾病。

Effect of ticlopidine on thromboxane B_2 production by platelets

噻 氯 匹 定对血小板血栓烷B2生成的影响

Observation of Efficacy and Safety of Aspirin and Ticlopidine on Prevention of Acute Cerebral Infarction

阿司匹林与 噻 氯 匹 啶预防急性脑梗死的疗效与安全性观察

Combination of asprin 、 ticlopidine 、 heparin in the prevention of subacute stent thrombosis

阿司匹林、 噻 氯 匹 啶、肝素预防冠状动脉支架亚急性血栓形成的效果

Objective To learn the security of ticlopidine by observing its short-term adverse effect in treating patients with coronary atherosclerotic heart disease .

目的本文观察应用 噻 氯 匹 定治疗冠心病中患者的短期不良反应，以了解 噻 氯 匹 定的安全性。

The Clinic Study of Ticlopidine for Prevention Hypertension and Thrombosis Induced by Recombinant Human Erythropoietin

抵 克力得预防重组人类促红细胞生成素诱发 顽固性高血压和血栓症的临床研究

Methods : 52 CAD patients with coronary spasm were randomly assigned to receive ticlopidine aspirin or Ticlid for6 months .

方法：对52例冠心病存在冠脉痉挛的患者，随机分为阿司匹林治疗组和抵 克力得治疗组。

OBJECTIVE : To provide information for clinical rational usage of ticlopidine and clopidogrel .

前言：目的：为临床合理使用 噻 氯 吡 定和氯吡格雷提供参考。

CONCLUSION : Ticlopidine is effective for treating acute cerebral infraction and decreasing the rate of platelet aggregation .

结论： 噻 氯 匹 定可用于脑梗死急性期的治疗，抑制血小板聚集是其重要的治疗机制。

Evaluation of Pharmacological Property and Clinical Application of Ticlopidine and Clopidogrel

噻 氯 吡 定和氯吡格雷的药理学特性与临床应用评价

AIM : To compare the efficacy and safety of clopidogrel on anti platelet aggregation with ticlopidine .

比较阿司匹林和 噻 氯 匹 啶 预防 脑 卒中 复发 的 长期药物经济学效果。

Pharmacokinetics of ticlopidine capsules and tablets in healthy volunteers

抵 克力得胶囊及片剂的药动学研究

Open sided sequential design adopted in the present study to examine the effects of short course treatment with ticlopidine no platelet aggregation induced by adenosine diphosphate ( ADP ) at low doses .

采用开放型单向序贯设计，检测了小剂量、短疗程 抵 克立得治疗对ADP诱导的血小板聚集性的影响。

Adverse drug reaction during ticlopidine treatment

噻 氯 匹 定的药物不良反应 概述

Effects of Ticlopidine and Ligustrazine on Platelet Agglutination in Patients with Ischemic Cerebral Infarction

抵 克力得与川芎嗪对缺血性脑卒中血小板聚集性的影响

Effects of ticlopidine on activation of platelet in type 2 diabetes mellitus

噻 氯 匹 定对2型糖尿病病人血小板活化状态的影响

To observe an efficacy of combination of aspirin ticlopidine and heparin in the prevention of subacute stent thrombosis ( SST ) .

目的观察阿司匹林、 抵 克力得和肝素预防亚急性冠状动脉支架血栓形成（SST）的有效性。

OBJECTIVE : To compare the impacts of Ligustrazine and Ticlopidine on platelet aggregation in ischemic cerebral apoplexy patients to provide an objective gist for the medication in cerebral apoplexy prevention .

目的：比较川芎嗪与 噻 氯 匹 定对缺血性脑卒中患者血小板聚集性影响，为预防脑卒中复发用药提供客观依据。

Objective To observe the effect of combination of aspirin ticlopidine low molecular weight heparin ( LMWH ) in prevention of subacute stent thrombosis ( SST ) .

目的观察阿司匹林、 噻 氯 匹 啶、低分子量肝素预防亚急性冠脉支架血栓形成（SST）的效果。

These results suggested that antiplatelet efficacy of ticlopidine was shown in part to inhibit arachidonic acid metabolism of platelets .

噻 氯 匹 定的抗血小板作用 至少有部分与抑制花生四烯酸的代谢有关。

Inhibition of Ticlopidine to Thromboxane B_2 in Cerebral Thrombosis

噻 氯 匹 啶对脑血栓病人的血栓烷B2的抑制

The Effect of Ticlopidine on Platelet Aggregation Function and Blood Viscosity

抵 克力得对血小板聚集功能及血液流变学的影响